Showing 1981-1990 of 9125 results for "".
The Case for JAK Inhibitors to Treat AD
https://practicaldermatology.com/topics/atopic-dermatitis/case-jak-inhibitors-treat-ad/27109/E. James Song, MD, FAAD, Director of Clinical Research and Co-Chief Medical Officer for Frontier Dermatology, discusses his presentation “JAK Inhibitors in Atopic Dermatitis” from the 2024 American Academy of Dermatology (AAD) Innovation Academy.We Can Do Better
https://practicaldermatology.com/columns/clinical-focus-1/we-can-do-better/23901/Dermatologists must educate primary care physicians on prevention and screening.At Your Service: Championing Employee Leadership
https://practicaldermatology.com/topics/practice-management/at-your-service-championing-employee-leadership/23793/How to develop engaged staff members who perform at the owner level.Novel Approaches to Nonmelanoma Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/novel-approaches-to-nonmelanoma-skin-cancer/23696/New and emerging treatment options are advancing care for patients with NMSC.Dermatology Marketing Trends for 2022 and Beyond
https://practicaldermatology.com/topics/practice-management/dermatology-marketing-trends-for-2022-and-beyond/23658/Relationship-building remains the predominant theme in digital marketing.Updates on Lasers for Skin or Color
https://practicaldermatology.com/topics/skin-cancer-photoprotection/updates-on-lasers-for-skin-or-color/23594/Continued advancement in technology is expanding safe and effective treatment for a greater number of patients.Melanoma in Skin of Color: More to Learn
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-in-skin-of-color-more-to-learn/23486/With evidence showing that cumulative UV exposure is not strongly correlated with melanoma risk in patients with skin of color, dermatologists must re-consider their messaging.Endo’s Qwo for Treatment of Cellulite
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/endos-qwo-for-treatment-of-cellulite/23466/Launching soon, the first injectable to target cellulite performed well in clinical trials.RIP Clarisonic, Hello New Contenders
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/rip-clarisonic-hello-new-contenders/23354/CSF faculty share top picks for at-home beauty devices.MIPS: The Secret to His Success
https://practicaldermatology.com/topics/practice-management/mips-the-secret-to-his-success/23117/Windsor Dermatology’s Dr. David Nieves shares his successful MIPS action plan.